Search company, investor...

Resonant Medical


Acquired | Acquired

Total Raised




About Resonant Medical

Resonant Medical develops, manufactures and commercializes 3D ultrasound image-guided adaptive radiotherapy products.

Headquarters Location

2050 Bleury Street, Suite 200

Montreal, Quebec, H3A 2J5,


877.985.2442 or 514.985.2442

Missing: Resonant Medical's Product Demo & Case Studies

Promote your product offering to tech buyers.

Reach 1000s of buyers who use CB Insights to identify vendors, demo products, and make purchasing decisions.

Missing: Resonant Medical's Product & Differentiators

Don’t let your products get skipped. Buyers use our vendor rankings to shortlist companies and drive requests for proposals (RFPs).

Resonant Medical Patents

Resonant Medical has filed 1 patent.

patents chart

Application Date

Grant Date


Related Topics




Gastropod anatomy, Image processing, Transcription factors, Medical imaging, Mollusc shells


Application Date


Grant Date



Related Topics

Gastropod anatomy, Image processing, Transcription factors, Medical imaging, Mollusc shells



Latest Resonant Medical News

Resonant Medical Secures Largest Medical Device Venture Capital Financing In Canada -- NULL

Aug 30, 2013

Resonant Medical Secures Largest Medical Device Venture Capital Financing In Canada MONTREAL, Dec. 15 /PRNewswire/ - Resonant Medical Inc., the technology leader in 3D ultrasound image-guided adaptive radiotherapy, announced today a $24 million Series B financing. The round was led by Ventures West and existing investor MDS Capital. Also participating were current investors BDC Venture Capital, Desjardins Venture Capital, MSBi Capital along with MMV Financial. This represents the largest venture capital investment raised by a private Canadian medical device company this year and the third largest in Canadian History. (x) "Resonant has demonstrated impressive growth and has successfully achieved important R&D, operational and commercial milestones. Resonant is now poised to deliver unique and indispensable product offerings to the radiation oncology marketplace," explains Dr. Maha Katabi, Vice-President of Ventures West. "We are now fully empowered to protect and increase our innovation and technology lead," announced Frederic Francis, CEO of Resonant Medical. "Thanks to the strong support of such top tier institutional investors, Resonant can fulfill its promises to our growing customer base and their patients. This means not only continuing to deliver the best available image-guidance for prostate cancer but also dedicating ourselves to achieving the same impact with our upcoming head & neck, breast and gynecological applications. " "We have reinvested in a first-rate organization with a solid track record and a commitment to excellence," adds Dr. Anthony Natale, Venture Partner at MDS Capital. "With this significant financial milestone, Resonant Medical is ensuring its role as the benchmark provider of image guidance for 3D conformal, intensity-modulated and adaptive radiation therapies. " Resonant's proprietary 3D ultrasound (U/S) technology allows clinicians to target tumors more accurately while safeguarding surrounding healthy tissues. Using Restitu(TM), Resonant's 3D U/S image guidance platform, radiation oncologists and medical physicists can now visualize and analyze tumor position, shape and volume during the course of patient treatment. The Restitu Platform is FDA 510k cleared and is presently being used in dozens of academic centers and cancer clinics throughout North America. The Restitu platform features significant hardware and software advances that enable physicians to achieve the level of confidence required to plan and deliver today's ever more conformal radiotherapy treatments. These features include such patent-pending technologies as Mutual Referencing(TM) which allows for ultimate patient position verification accuracy as well as Implicit Registration(TM), that permits the fusion of computed tomography (CT) and 3D U/S images for a new level of detail for radiation treatment planning. "Resonant's progress has been remarkable since our original investments," adds Dr. Lewis Slotin, seed co-investor in Resonant Medical. "Resonant now has the opportunity and resources to realize our initial vision of bringing forward breakthrough technologies that will revolutionize the way cancer patients are treated. " About Ventures West Ventures West Management Inc., a private venture capital investment group, is one of Canada's leading investors in early stage technology companies. Since its founding in 1968, Ventures West has formed eight venture capital funds representing over $700 million and has invested in more than 130 companies. Ventures West commands the expertise, capital and people needed to help entrepreneurs shape emerging technology companies into market leaders. About MDS Capital MDS Capital Corp. and affiliates, with approximately $1 billion under management, is a leading North American venture capital company focused exclusively on providing financial support and other services to help build emerging life science companies. The company provides a continuum of capital, from early through later stages, by raising capital in public and private institutional funds. About Desjardins Venture Capital Established in 1974, Desjardins Venture Capital is the venture capital fund management arm of the Desjardins Group. It manages the assets of Desjardins, six Desjardins regional investment funds and "Capital regional et cooperatif Desjardins", a public fund created in 2001 with authorized capitalization of $1.375-billion. About MSBi Capital MSBi Capital is a seed and early stage venture capital fund dedicated to commercializing innovations in life sciences, information technology and the physical sciences. MSBi Capital has a particular focus on establishing and building companies based on technology advancements and inventions originating from the universities of McGill, Sherbrooke and Bishop's, as well as their affiliated hospitals and research institutes. About MMV Financial MMV Financial is a Toronto-based specialty finance company providing creative debt solutions directly to mid-stage technology and life sciences companies, with a focus on the Canadian and North American sectors. MMV is backed by top U.S. and Canadian private equity firms and financial institutions including Conning Capital Partners of Hartford, Connecticut, Caisse de depot et placement du Quebec of Montreal, and Wells Fargo Foothill, a part of Wells Fargo Company. About Resonant Medical Inc. Resonant Medical Inc. is a leader in 3D ultrasound image-guided adaptive radiotherapy products which are intended to make an important contribution to the treatment of cancer through radiotherapy in the area of treatment planning, verification and delivery. The company's core product, the Restitu Platform, is designed to increase the efficacy and reduce the side effects of radiation therapy, resulting in improved quality of life for cancer patients as well as enhanced productivity of cancer centers. (x) Source: Thomson MacDonald SOURCE RESONANT MEDICAL INC.

Resonant Medical Frequently Asked Questions (FAQ)

  • Where is Resonant Medical's headquarters?

    Resonant Medical's headquarters is located at 2050 Bleury Street,, Montreal.

  • What is Resonant Medical's latest funding round?

    Resonant Medical's latest funding round is Acquired.

  • How much did Resonant Medical raise?

    Resonant Medical raised a total of $24M.

  • Who are the investors of Resonant Medical?

    Investors of Resonant Medical include Elekta, Ventures West, MSBi Capital, Desjardins, BDC Healthcare Venture Fund and 6 more.

  • Who are Resonant Medical's competitors?

    Competitors of Resonant Medical include Ultrasound Medical Devices, Insight Imaging, VidiStar, Signostics, TrueVision Systems and 13 more.

Compare Resonant Medical to Competitors


Luminetx Corporation discovers, develops, and commercializes bioscience technologies.

Insight Imaging

Insight Imaging is a provider of on-site, diagnostic ultrasound services in the country. They deliver ultrasound services in the convenience of providers' practice suites, clinics, hospitals and other settings.

Esaote Logo

Esaote is a producer of medical diagnostic systems, including ultrasound and MRI equipment.


Gammex is engaged in manufacturing and distribution of quality control devices for ultrasound, mammography, medical imaging and laser alignment systems.


InnerOptic is a medical device startup focused on the integration of 3D ultrasound imagery and surgery.

VueSonix Sensors

VueSonix is a medical imaging company developing vascular imaging, diagnosis and monitoring systems using ultrasound as the enabling media. VueSonix was founded upon the recognition that current devices do not adequately serve vascular markets. The company's founders are commercializing intellectual property to develop ultrasound devices.

Discover the right solution for your team

The CB Insights tech market intelligence platform analyzes millions of data points on vendors, products, partnerships, and patents to help your team find their next technology solution.

Request a demo

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.